This has led researchers to investigate medications that modulate these systems, including the glucagon-like peptide-1 (GLP-1) receptor agonists originally developed for type 2 diabetes and obesity management
Jessica Drummond 00:48:25 So I think as practitioners, we have to constantly be just noticing where we carry those things for ourselves and for our patients so that they can use these tools
Metabolic labeling was done in triplicate with similar outcomes
Chi, L., Ke, Y., Luo, C., Gozal, D
Semaglutide's ability to regulate appetite and promote weight loss can complement the effects of NRT and other medications, making it easier for individuals to manage withdrawal symptoms and maintain their attempts to quit smoking